We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Home Office circular 49 / 2005 Testing for presence of (specified) Class A drugs and Assessment of Misuse of Drugs Broad subject: Crime…
First published during the 2005 to 2010 Labour government
First published during the 2022 to 2024 Sunak Conservative government
Statistics on alcohol and drug misuse treatment for adults, from PHE’s National Drug Treatment Monitoring System (NDTMS).
ACMD 1-benzylpiperazine (BZP) Report (2008) Date: Thu May 21 10:15:17 BST 2009 Full Document ACMD 1-benzylpiperazine (BZP) Report (2008…
Findings from the National Drug Treatment Monitoring System (NDTMS) about the number of adults and young people in contact with alcohol and drug treatment services in prisons and other secure settings.
This research reports the findings from a trial that aimed to improve message acceptance to the risks of using substances, reduce substance use, increase engagement in drug treatment and improve prison behaviour.
Figures on methylphenidate base and methylphenidate hydrochloride importation between 2010 and 2012 were requested.
Statistics on alcohol and drug misuse treatment for adults from PHE’s national drug treatment monitoring system (NDTMS).
Government response to the 12th report from the home affairs committee session.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Monthly PDF editions of the Drug Safety Update newsletter from MHRA and its independent advisor, the Commission on Human Medicines
The First Twelve Months of a Prospective Cohort Study
First published during the 2015 to 2016 Cameron Conservative government
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).